Poland· PL-100025534
GAMMA anty-HBs 200
A hepatitis b immunoglobulin product containing immunoglobulinum humanum hepatitidis b. immunoglobulina ludzka przeciw wirusowemu zapaleniu wątroby typu b, registered in Poland by Synthaverse S.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Hepatitis b immunoglobulin is registered in 12 of 19 countries.
Countries holding a registration under ATC J06BB04 (hepatitis b immunoglobulin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Hepatitis b immunoglobulin · ATC J06BB04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Immunoglobulinum humanum hepatitidis B. Immunoglobulina ludzka przeciw wirusowemu zapaleniu wątroby typu B
- Manufacturer
- Synthaverse S.A.
- Country
- Poland (PL)
- ATC code
- J06BB04
- ATC class
- Hepatitis B immunoglobulin
- Defined daily dose
- 500 E, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990060917
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hepatitis b immunoglobulin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHepatect CP 100units/2ml solution for infusion vialsBiotest (UK) Ltd
- SwitzerlandHepatect CP, InfusionslösungBiotest (Schweiz) AG
- SpainHEPATECT 50 UI/ml SOLUCION PARA PERFUSIONBiotest Pharma Gmbh
- Japan乾燥抗ＨＢｓ人免疫グロブリン
- FranceIMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB 100 UI/mL, solution injectable en seringue préremplie (IM)LFB-BIOMEDICAMENTS
- CanadaHEPAGAM BKI BIOPHARMA LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb0989aa-06c4-4616-9d9c-0417b82a4483 GET /v1/drugs/eb0989aa-06c4-4616-9d9c-0417b82a4483?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "200 j.m./ml",
"packaging": "05909990060917 ¦ Rp ¦ 58515\n1 amp. 1 ml",
"substance": "Immunoglobulinum humanum hepatitidis B 200 j.m.",
"common_name": "Immunoglobulinum humanum hepatitidis B. Immunoglobulina ludzka przeciw wirusowemu zapaleniu wątroby typu B",
"pl_product_id": "100025534",
"pozwolenie_nr": "00609",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about hepatitis b immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.